Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Infection, inflammation, height, and longevity
2005 Standout
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
2004
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
IL‐1β induces COX2, MMP‐1, ‐3 and ‐13, ADAMTS‐4, IL‐1β and IL‐6 in human tendon cells
2003
Prognostic Factors in Non-small Cell Lung Cancer
2002
Coronary artery apoptosis in experimental hypercholesterolemia
1999
The T cell response against fungal infections
1997
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.
1998
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
2002 StandoutNature
Burnout and risk of cardiovascular disease: Evidence, possible causal paths, and promising research directions.
2006
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
INDUCTION OF PROINFLAMMATORY AND CHEMOKINE GENES BY LIPOPOLYSACCHARIDE AND PACLITAXEL (Taxol™) IN MURINE AND HUMAN BREAST CANCER CELL LINES
2001
Effect of Mechanical Ventilation on Inflammatory Mediators in Patients With Acute Respiratory Distress Syndrome
1999 Standout
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer
2001
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
1998
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
2002 StandoutNobel
Programmed cell death in Caenorhabditis elegans
1994 StandoutNobel
Inflammation, stress, and diabetes
2005 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Lysosomal storage disorders
2005
Inflammation and Colon Cancer
2010 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
2016
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
2001 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment
2001
Inflammation and cancer: back to Virchow?
2001 Standout
New separation tools for comprehensive studies of protein expression by mass spectrometry
2000
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites
1999
A sensitive amperometric immunosensor for carcinoembryonic antigen detection with porous nanogold film and nano-Au/chitosan composite as immobilization matrix
2007
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Vascular endothelial growth factor (VEGF) in endometriosis
1998
Endometriosis
2004 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Tendon Injury and Tendinopathy
2005 Standout
Neutrophils in cancer: neutral no more
2016 Standout
The Role of Interleukin-1 in Disease
1993
Immunity to fungal infections
2011 Standout
Cancer-related inflammation
2008 StandoutNature
Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
2002
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
2006
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
1998
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells
2005
Getting to the “COR”
2014 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic Target
1994
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
2001
Soluble receptors in human disease
1998
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting
1996
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis
2000
Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
1999
IL-1 is required for tumor invasiveness and angiogenesis
2003
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Inflammation and Atherosclerosis
2002 Standout
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
1998 Standout
Tumor Necrosis Factor (TNF)-alpha and TNF Receptors in Viral Pathogenesis
2000
Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes
2001
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
1997 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia
2002
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
2000
Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages
2003 StandoutNobel
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
Differential Effects of IL-1α and IL-1β on Tumorigenicity Patterns and Invasiveness
2003
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
T helper cell activation and human retroviral pathogenesis
1996
Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF
2004 StandoutNobel
55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages
1997
Soluble cytokine receptors
1996
Dual‐Amplification of Antigen–Antibody Interactions via Backfilling Gold Nanoparticles on (3‐Mercaptopropyl) Trimethoxysilane Sol‐Gel Functionalized Interface
2007
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease
1999
Works of V. Barak being referenced
Imbalance of immune responses in patients with chronic and widespread fungal skin infection
1995
Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
1997
Cytokeratin Markers in Malignant Pleural Mesothelioma
1998
High concentration of soluble interleukin-2 receptors in ejaculate with low sperm motility
1994
The M20 IL-1 inhibitor
1992
Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures
1991
Cytokines in Gaucher's disease.
1999
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
2000
1259 CYFRA 21-1 and TPS—new markers in lung cancer
1995
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection
1992
Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors
1992
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
1999
Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.
1996